USE OF CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF DRY EYE SYNDROME - Patent 2785363

(19)

(11)

EP 2 785 363 A1

(12)

(43)	Date of publication:
	08.10.2014 Bulletin 2014/41

(21)	Application number: 12798160.3

(22)	Date of filing: 30.11.2012

(51)

International Patent Classification (IPC):

A61K 38/08^(2006.01)
A61K 38/17^(2006.01)

A61K 38/10^(2006.01)
A61P 27/02^(2006.01)

(86)	International application number:
	PCT/EP2012/004952

(87)	International publication number:
	WO 2013/079213 (06.06.2013 Gazette 2013/23)

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30)

Priority:

30.11.2011 WO PCT/EP2011/006003

(71)	Applicant: Xigen Inflammation Ltd.
	3030 Limassol (CY)

(72)	Inventors:
	COMBETTE, Jean-Marc. F-74140 Saint Cergues (FR) DELOCHE, Catherine. CH-1207 Genf (CH)

(74)	Representative: Graf von Stosch, Andreas et al
	Graf von Stosch Patentanwaltsgesellschaft mbH Prinzregentenstrasse 22 80538 München 80538 München (DE)

(54)	USE OF CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF DRY EYE SYNDROME